Tocilizumab degradation via photo-catalytic ozonation process from aqueous.

ABSTRACT: Following the advent of the coronavirus pandemic, tocilizumab has emerged as a potentially efficacious therapeutic intervention. The utilization of O₃-Heterogeneous photocatalytic process (O₃-HPCP) as a hybrid advanced oxidation technique has been employed for the degradation of pollutants. The present study employed a solvothermal technique for the synthesis of the BiOI-MOF composite. The utilization of FTIR, FESEM, EDAX, XRD, UV-vis, BET, TEM, and XPS analysis was employed to confirm the exceptional quality of the catalyst. the study employed an experimental design, subsequently followed by the analysis of collected data in order to forecast the most favorable conditions. The purpose of this study was to investigate the impact of several factors, including reaction

SUBMITTER: Mehralipour J 

PROVIDER: S-EPMC10725442 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature